July 13, 2021
Telehealth use drops for 3rd straight month as patients return to in-person appointments
Americans are slowly returning to medical facilities to receive care and are using fewer telehealth services after last year's pandemic high, according to new data.
July 3, 2021
Coronavirus Pandemic Driving Increase in Healthcare Consolidation
Easing regulatory burdens is crucial to the future of independent physician practices, Richele Taylor, JD, CEO and chief legal officer of the South Carolina Medical Association, told HealthLeaders. "The regulatory burdens are important because it is hard for a new physician to start a practice, and you want to keep independent practices viable especially in rural and underserved areas. It has got to be something they can do. They have got to be able to run a practice while practicing medicine."
June 29, 2021
Advisory: Warning about potent counterfeit Roxicodone® (“blue pills”), dangers of using drugs purchased without prescriptions
The OERT is issuing an alert due to ongoing substance use and overdose activity in Greenwood and Union counties and surrounding areas connected with counterfeit 30 mg Roxicodone® (AKA “blue pills”) containing potent fentanyl.
June 7, 2021
FDA’s Decision to Approve New Treatment for Alzheimer’s Disease
The FDA approved Aduhelm (aducanumab) to treat patients with Alzheimer’s disease using the Accelerated Approval pathway.
May 13, 2021
CDC Director Statement on Pfizer’s Use of COVID-19 Vaccine in Adolescents Age 12 and Older
Today, I adopted CDC’s Advisory Committee on Immunization Practices’ (ACIP) recommendation that endorsed the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine and its use in 12- through 15-year-old adolescents. CDC now recommends that this vaccine be used among this population, and providers may begin vaccinating them right away.
April 23, 2021
FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review
Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.
April 14, 2021
Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine
The CDC and the FDA are reviewing data involving six U.S. cases of a rare type of blood clot in individuals after receiving the Johnson & Johnson (J&J) COVID-19 vaccine that were reported to the Vaccine Adverse Events Reporting System (VAERS).
April 8, 2021
Class action lawsuit filed against Roper St. Francis Healthcare over data breach
A lawsuit has been filed against Roper St. Francis alleging a breach of private patient data, including financial and medical information, was compromised.
April 2, 2021
CDC Issues Updated Guidance on Travel for Fully Vaccinated People
The Centers for Disease Control and Prevention (CDC) updated its travel guidance for fully vaccinated people to reflect the latest evidence and science.
